Biosimilar infliximab is effective and safe in inflammatory bowel disease patients naive to anti-TNF therapy: a tertiary center experience
Pathway
IBD
Conference
UEG Week 2016
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]
Social Sharing